Dr. Martin Rosenthal is named NHF's first medical director.

NHF hosts its first symposium where MASAC presents its findings.

Hemophilia of Michigan forms.

At a board meeting in Chicago, NHF hands over business functions from volunteers to official staff, an effort lead by board secretary Margaret Hexter, who lived in Illinois and had a son with hemophilia.

On February 21, 1956, a "Certificate of Change of Name of The Hemophilia Foundation, Inc., to "The National Hemophilia Foundation" is filed in the New York Department of State.

American pathologists Robert Langdell, Robert Wagner, and Kenneth Brinkhous develop intravenous infusions of factor VIII (8).

Dr. Kenneth Brinkhous is named as the first president of MASAC.

The first meeting of NHF's Medical and Scientific Advisory Committee (MASAC) is held.

Dr. Judith Graham Pool publishes her first research paper on hemophilia.

Chapters form in Rochester and Chicago.